It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.
But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 percent effective in preventing Covid-19.
With the virus raging, how strong is this new ray of hope?
Guest: Carl Zimmer,a science writer and author of the “Matter” column for The New York Times.
Background reading:
We want to hear from you. Fill out our survey about this show and others at nytimes.com/thedailysurvey.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More